Linhui Peng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC (NCT07267806) | Linhui Peng | 2025-10-31 |
Track Linhui Peng automatically
Every clearance here is in the API, with alerts when new ones post.